Abstract
Introduction
Pelizaeus-Merzbacher disease (PMD, OMIM312080) and spastic paraplegia type 2 (SPG2, OMIM312920) are X-linked hypomyelinating leukodystrophies caused by mutations in the proteolipid protein 1 (PLP1) gene that encodes the major central nervous system myelin proteins PLP and DM20 in oligodendrocytes [1, 2] . The clinical findings associated with PLP1 mutations span a broad-spectrum continuum extending from severe congenital PMD forms to relatively mild late-onset SPG2, leading to the concept of PLP1-related disorders [3, 4] . We previously classified patients according to the best motor function achieved between the ages of 2 and 5 years to demonstrate a genotype-phenotype correlation [3] . PMD1 (head control) and PMD2 (sitting position) are the most frequent forms and are usually associated with PLP1 duplications. Missense mutations are rare but usually cause the most severe forms without motor acquisitions and dystonia (PMD0, also named "congenital" forms). Myelin deficiency is the main histological feature in human and mouse models of these severe forms [5, 6] . PLP1 loss-of-function (null mutations and large deletions) leads to the mildest PMD3/SPG2 forms with the acquisition of walking capacities with/without aid and a relatively preserved cognitive development. Murine models and humans lacking PLP1 are characterized by axonal degeneration with a small enlargement of the interlamellar space of the myelin sheath [2, 7] . In all forms, the myelin deficiency is demonstrated by the extensive abnormalities of multimodal evoked potentials and the diffuse hypomyelinated pattern of the supratentorial white matter (WM) magnetic resonance imaging (MRI) [8] . Most patients clinically improve during childhood, just as patients with cerebral palsy (CP). Some progression of myelination is observed until 12 years of age [9] . The second decade is marked by neurological deterioration with cortico-subcortical atrophy on MRI, leading to severe quadriplegia, amyotrophy, optic atrophy, and cognitive decline in young adults, even in the mildest forms [10] . Several recent studies have underlined the correlation between clinical severity and brain atrophy on MRI [9, 11, 12] .
Using diffusion tensor imaging (DTI), Laukka et al. [13] found that the WM mean and radial diffusivities of 12 PLP1-mutated patients were higher than those of controls, in accordance with the severe myelin deficiency observed in PMD. Axial diffusivity, which is assumed to be more specific to axon properties, was much less affected, except in the most severely affected patients. Here, we investigate the ability of DTI parameters to distinguish the different severity groups (PMD0-1, PMD2, and PMD3-4) and to correlate with clinical severity in a cohort of 35 PLP1-mutated patients. We extended the WM analysis with tractography in an attempt to identify patterns of WM fiber damage.
Patients and Methods

Patients
Thirty-five patients from 32 families with a genetically-confirmed diagnosis of PLP1 mutation (19 duplications, 9 missense mutations, and 7 null mutations) were included in this prospective study from January 2004 to December 2009, after first obtaining approval from the institutional review board (CPP Sud-Est VI No. AU788, CNIL No. 1406552, AFSSAPS No. B90298-60) and signed informed consent from the parents. For MRI acquisition, sedation by intrarectal pentobarbital 3-5 mg/kg (maximum dose: 100 mg) and oral alimemazine (4% drops, 1 drop/kg, i.e., 1.25 mg/kg) was performed in patients aged under 6 years or requiring sedation to avoid movement artifacts.
Our study focused on a comparison of patients with distinct degrees of disease severity. Patients were classified according to the best motor developmental score (MDS) observed between the age of 2 and 5 years: PMD0, without motor acquisition (n = 4 patients); PMD1, head control (n = 5); PMD2, sitting position (n = 16); PMD3, walking with support (n = 8); PMD4, independent walking (n = 2). An 88-item gross motor function measure (GMFM) was assessed for all patients at the time of MRI acquisition for motor clinical severity [14] . MDS, GMFM, genotype, and ages at GMFM and MRI acquisitions are summarized in Table 1 . At the first MRI, the median age was 8.6 years (2.3-43.5). Quantitative DTI measures were obtained in 32 out of 35 patients at a median age of 8.6 years (2.3-41.0). Tractography was carried on in 24 out of 35 patients at a median age of 13.6 years (2.3-43.5). For some patients, we could not analyze quantitative DTI (n = 3) or tractography (n = 11) maps due to corrupted data after MRI acquisition. Data were considered corrupted when DTI and tractography software could not read DICOM series because of artefacts due to subject motion. For 8 patients, the quantitative DTI and tractography were analyzed on 2 different MRI scans at different ages to obtain noncorrupted data.
Diffusion Imaging and Parameters
Images were acquired on a 1.5-Tesla Siemens MR scanner under sedation. DTI acquisition used a single-shot echo-planar dual spin-echo sequence: repetition time = 3,600 ms, echo time = 85 ms, 90° flip angle; 6 diffusion gradients; b0 = 600 s/mm 2 ; 35 joined axial slices; 256 × 256 matrix; voxel size = 2 × 2 × 6 mm 3 ; total acquisition time = 6 min. T1-weighted, T2-weighted, and fluid-attenuated inversion recovery sequences were added for anatomical guidance (online suppl. Material 1; for all online suppl. material, see www.karger.com/doi/10.1159/000492218).
The DTI parameters fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) were computed with DTI studio (Jiang and Mori, Johns Hopkins University, cmrm.med.jhmi.edu or godzilla.kennedykrieger.org) using a multivariate linear fitting algorithm for diffusion tensor calculation [15] . We explored 26 regions of interest (ROI), 17 in su-Dev Neurosci 2018;40:301-311 DOI: 10.1159/000492218 pratentorial and infratentorial WM and 9 in cortical and deep grey matter (GM) (online suppl. Material 2), after automatic correction of eddy current distortion and automatic segmentation of ROI on the diffusion data based on Harvard-Oxford cortical and subcortical structural atlases (FSL, FMRIB Software Library, fsl.fmrib.ox. ac.uk).
Tractograms
Tractography was computed after correction of eddy current distortion, co-registration (mutual information algorithm), and anterior commissure-posterior commissure alignment. Right and left tractograms were generated by a trained neurologist (C.S.), using fiber assignment by continuous tracking [16] and tensor deflection [17] methods implemented within iPlan Stereotaxy 3.0 software (BrainLab, Feldkirchen, Germany). The FA threshold was set at 0.20 with a minimum fiber length tracking of 40 mm. For each tractogram, the volume and number of fibers (NOF) were computed and volume/total intracranial volume (TIV) and NOF/ TIV ratios were calculated. TIV was preferred over brain volume for normalization to consider brain growth in children and progressive atrophy in adults. The tractograms were interpreted at the individual level and visually compared against 2 control subjects (aged 8 and 41 years) by 2 experienced neurologists (C.S. and J.-J.L.), using the following morphological criteria of fibers bundles: (1) size: large, small, lacking; (2) direction of main-stream fibers (DMSF): anterior-posterior (longitudinal), lateral-medial (trans- Genotype at the DNA level. n.a., not available a Family genetic number corresponds to our laboratory family number and refers to a previous publication [3] .
DOI: 10.1159/000492218 versal), superior-inferior (vertical); (3) connectivity, irrespective of direction, e.g., fugal or petal: extratelencephalic projections (ETP), commissural fibers (CF), and intrahemispheric connections (IHC).
Statistical Analyses
Statistical analysis was performed using Stata 13 software (StataCorp, College Station, TX, USA). The tests were two-sided, with a type-I error set at α = 0.05. Quantitative data, expressed as mean and standard deviation or median and minimum-maximum ages according to statistical distribution, were compared between 3 independent groups (PMD0-1, PMD2, and PMD3-4) using a Kruskal-Wallis test followed by the appropriate post hoc Dunn test. ANCOVA was performed with age as the adjustment covariate. The assumption of the normality of residuals was also studied using the Shapiro-Wilk test. Data exhibiting nonnormal distributions, a log-transformation was proposed to achieve normality of several variables and to allow the correct use of these analyses. We chose to report all individual p values without doing any mathematical correction for distinct tests comparing groups [18] . A focus was given to the magnitude of improvement and to the clinical relevance [19] . Results were expressed as effect sizes and 95% confidence intervals and can be compared to the effect size bounds proposed by Cohen [20] ; i.e., small (±0.2), medium (±0.5), and large (±0.8, "grossly perceptible and therefore large"). Finally, a nonparametric Spearman's correlation test, with Sidak's type I error correction, was used to compare individual quantitative DTI parameters and GMFM.
Results
Patient Severity
The best MDS of the 32 patients analyzed with quantitative DTI were classified as follows: PMD0-1 (n = 8), PMD2 (n = 14), and PMD3-4 (n = 10), with median ages of 8. The level of the motor handicap at the time of the MRI acquisition was evaluated in the 32 patients using the GMFM. Comparison of the mean GMFM adjusted to age between the 3 MDS groups showed that GMFM was higher in PMD3-4 than PMD0-1 and PMD2. It was also higher in PMD2 than PMD0-1 but not significantly (Fig. 1) .
Quantitative Diffusion Parameters
Results of FA, MD, AD, RD in 17 ROI of WM, and 9 ROI of GM are shown in Figure 2 (online suppl. Table 1 for values and online suppl. Fig. 1 for effect sizes and 95% confidence intervals). We found that FA was significantly lower in PMD2 than PMD3-4 in the middle cerebellar peduncle, in PMD0-1 than PMD2 in the middle temporal gyrus, right caudate nucleus, and right thalamus, and in PMD0-1 than PMD3-4 in the postcentral gyrus. MD was significantly higher in PMD0-1 than PMD2 in the superior cerebellar peduncle, frontal pole, and left caudate nucleus, and in PMD0-1 than PMD3-4 in the superior cerebellar peduncle. AD was significantly higher in PMD0-1 than PMD2 in the superior cerebellar peduncle, left posterior and right superior corona radiata, frontal pole, and left caudate nucleus, and in PMD0-1 than PMD3-4 in the left superior cerebellar peduncle and right superior corona radiata. RD was significantly higher in PMD0-1 than PMD2 in superior cerebellar peduncle, frontal pole, middle temporal gyrus, caudate nuclei and thalami, and in PMD0-1 than PMD3-4 in the right superior cerebellar peduncle and right caudate nucleus. Motor abilities, evaluated by the GMFM performed at the time of MRI, showed a relatively strong negative linear correlation with MD (p < 0.043) and AD (p < 0.036) in the superior cerebellar peduncles. Other possible strong linear relations were observed with MD, AD, or RD in the anterior corona radiata but were not statistically significant ( Fig. 3 ; online suppl. Table 2 ).
Tractograms
Volume/TIV and NOF/TIV ratios were higher in PMD3-4 than in other groups (p < 0.02) after adjustment to age, considering an older age of PMD3-4 patients at MRI acquisition (Fig. 4 , online suppl. Table 3 ). ETP appeared relatively preserved in all groups. CF were variably individualized in all groups, ranging from large fibers (n = 9) to small fibers (n = 8) or a lack of connectivity (n = 7). IHC size was dependent on clinical severity, being clearly smaller (n = 8) or lacking connectivity (n = 4) in PMD2 and PMD0-1 patients. The DMSF of IHC was analyzable in 9 out of 9 PMD3-4 patients and in 10 out of 12 PMD2 patients, and the analysis showed a major tracking of longitudinal fibers in 18 out of 19 patients, whereas 1 patient had major transversal fibers ( Fig. 5A ; online suppl. Fig. 2, 3 ). There were age-dependent differences in the PMD2 group, with smaller CF and IHC in the youngest and oldest patients while patients in late childhood had the largest projections ( Fig. 5B ; online suppl. Fig. 2,  3 ).
Discussion
Here, we analyzed quantitative DTI measures and tractography patterns from acquisitions performed at the same medical center in a large cohort of PLP1-mutated male patients to investigate the ability of these technics to distinguish severity groups. Our 35 patients were representative of the broad clinical spectrum observed in PLP1-related disorders: 46% classical PMD2 forms, 26% severe PMD0-1 forms, and 28% mild PMD3-SPG2 forms. For clinical classification, we used the MDS previously demonstrated to correlate to the genotype [3] . To correlate motor skills at the time of MRI, we used GMFM [14] , a validated clinical score in CP that is widely used in the quantification of motor abilities in leukodystrophic patients. Comparison of the mean GMFM between MDS groups argued as in CP for a correlation between the level of the best motor development always observed before 5 years of age and the severity of the motor disabilities later in life. This study shows that quantitative DTI parameters in supratentorial WM are insufficient to distinguish the clinical severity in PLP1-mutated patients, whereas increased isotropic diffusion in cortical and deep GM and in infratentorial WM was clinical severity linked. We also found clinical severity-dependent differences in quantitative and descriptive tractography.
Laukka et al. [13] previously identified increased MD and RD and decreased FA in supratentorial WM regions in 12 PMD patients compared to controls, as expected in hypomyelinating brains. Steenweg et al. [21] also found that RD in supratentorial WM was inversely correlated with motor handicap in a cohort of 28 patients with various hypomyelinating disorders. Here, comparison of the MDS groups of our PLP1-mutated patients failed to differentiate clinical severity using quantitative DTI parameters in supratentorial WM. A previous study in the same cohort of patients was unable to classify clinical severity using a myelination score on conventional MRI [9] . Moreover, motor abilities at the time of MRI using GMFM did not significantly decrease with increasing diffusion in supratentorial WM. These results confirmed that increased diffusion and decreased myelination score on the supratentorial WM demonstrate the myelin defect but may not serve to classify the clinical severity observed in PLP1-related disorders. Factors that may have limited the ability of this study to identify differences include the small sample sizes in each group, the broad age ranges in the patients, or the algorithms and tools used in the quantitative analyses. Other factors could be an offset between microarchitectural changes and clinical features. Progression in both motor acquisitions and myelination are observed in the first decade of life but followed by motor and cognitive decline and progressive cerebral atrophy [9] , so microarchitectural changes in supratentorial WM may precede clinical changes, creating a time gap between diffusion data and clinical data.
In infratentorial WM, the clinical severity of the MDS groups and motor abilities at the time of MRI were in accordance with the DTI parameter values, except FA. This result was surprising, as infratentorial WM is usually well myelinated on structural MRI in PLP1-related disorders regardless of clinical severity [19] . However, Laukka et al. [13] also found changes in MD and RD in the cerebellar peduncle of PMD patients compared to controls. Moreover, infratentorial abnormalities had been described in a DTI study by Hassen et al. [22] who found MD, AD, and RD variations in the spinal cord of a SPG2 mouse model. These results suggest that PLP1-mutated patients present subtle changes in the infratentorial WM microarchitecture. This idea is consistent with (i) the early and predominant signs of cerebellar dysfunctions observed in PMD patients; (ii) the correlation we had previously found between clinical severity and cerebellar atrophy [9] ; and (iii) the neuropathological analysis of PMD patients with cerebellar abnormalities [23] . In this study, we found a higher AD and RD in the most severely affected patients. Laukka et al. [13] also found changes in AD, which is supposed to reflect axonal integrity, in only the most severely affected patients, whereas RD, which may reflect myelin integrity, was increased in all forms. In cortical and deep GM, the clinical severity of the MDS groups increased with the increase of diffusion (MD, AD, and RD) in several regions. Moreover, diffusion was more isotropic (decreased FA) in GM in the most severely affected patients. To date, in PLP1-related disorders, there are no reports of DTI analysis of GM, but Laukka et al. [13] and our team [9] have already shown a clear cerebral atrophy including the GM compartment and correlating with clinical severity. Hassen et al. [22] also found an MD increase in the GM of the spinal cord in a SPG2 mouse model. Increased diffusion in cerebral GM has been reported in multiple sclerosis, where it appears to correlate with motor and cognitive decline [24, 25] , and in an animal model of genetic demyelinating disorder [26] . However, contrary to our patients, isotropic diffusion decreased (increased FA) in the cortex in multiple sclerosis as a probable result of local activation and proliferation of microglia characterized by the loss of ramifications and acquiring a more anisotropic, bipolarly oriented structure, as observed in active acute and chronic cortical lesions [25] . In PLP1-related disorders, it may corroborate with (i) the neuron loss, demyelination, and axonal damage reported on neuropathological analysis of PLP1-mutated animal models [27] and PMD/SPG2 patients [23] ; (ii) the absence of local microglial activation; and (iii) the neuronal PLP1 expression found in mice and humans [28, 29] . These results underline that GM is clearly involved in the severity of PLP1-related disorders.
Tractography was possible in PLP1-related disorders, including severe forms. Quantitative parameters, including tractogram volumes and NOF, which have already been used in previous studies [30, 31] , permitted to distinguish the mildest forms from other forms. Descriptive analyses of fiber bundles showed a preservation of ETP and an altered organization of intra-and interhemispheric connections in all patients, mostly with a loss of vertical and transversal connectivity and an apparent overrepresentation of longitudinal fibers. This suggests that tractography assessment is easy in monodirectional and partially myelinated fibers but remains difficult in multidirectional and less myelinated fibers in hypomyelinating disorders. Descriptive analyses also revealed an age-dependent evolution of the tractograms in the largest classical-intermediate group. For the youngest patients, the increasing size of tractograms may correspond to different stages of myelination. While healthy 2-year-old children have already achieved myelination except in subcortical fibers, severe supratentorial hypomyelination is the main feature in PLP1-related disorders [10] , where myelination can partially improve until 12 years of age [9] . For adult patients presenting severe cerebral atrophy on conventional MRI, the decreased size of tractograms may reflect WM atrophy or loss of connectivity. Laukka et al. [11] , argued prominent WM atrophy in PMD/SPG2 patients, whereas we observed parallel WM/GM atrophy over time on conventional MRI [9] . Taken together, the combination of patients' clinical evolution, progressive global atrophy, GM microstructure changes on DTI, and progressive WM fiber disappearance on tractography converge to confirm that PLP1-related disorders are global central nervous system diseases affecting both WM and GM.
This study has several limitations. First, recent studies suggested the potential for seemingly minor alterations in data acquisition, particularly the b-value and number of diffusion gradient directions, to influence the DTI parameters [32] . Moreover, using multiple b-values such as recent technique called neurite orientation dispersion and density imaging could provide additional informa- Examples of tractograms for each group of severity and a table of the results of morphological analyses in 24 patients for whom tractography was available: PMD0-1 (n = 3), PMD2 (n = 12), and PMD3-4 (n = 9). ETP were relatively preserved in all groups but were smaller than in controls. Compared to controls (a, e), CF and IHC were smaller or lacking in all groups: the most severe PMD0-1 (b, f), the classical PMD2 (c, g), and the mildest PMD3-4 cases (d, h). DMSF in IHC was marked by longitudinal (or rare transversal) overrepresentation. B. Each image corresponds to tractograms of PMD2 patients of different ages. These results show that the youngest patients (a, b) had less developed ETP, CF, and IHC than patients at the late infancy (c, d) and adolescent patients (e, f); the oldest patients (g, h) had smaller ETP, CF, and IHC than adolescent patients (e, f).
DOI: 10.1159/000492218 tion on tissue compartments [33] . Further studies should consider these parameters. Second, with only 6 gradient directions, tractography can be limited to only major fiber tracts and can underestimate the connectivity. Our goal to differentiate severity in PLP1-related disorders was achieved in this protocol, but it would be interesting to increase the number of directions to study weak connections. Finally, even if we considered the age of the subjects as a covariate, there is an age difference between the patient groups that could generate a bias of interpretation. We did not report the intraindividual evolution of DTI parameters and tractography. This would be a different study that could help strengthen our results.
In conclusion, this study shows for the first time that tractography can be a useful and noninvasive technique for the investigation and follow-up of hypomyelinating disorders. Our findings also bring further evidence of physiopathological mechanisms in PLP1-related disorders that likely involve both GM and WM and infratentorial structures. These findings must be confirmed in further studies and may be important for the development of new therapeutic strategies targeting not only oligodendrocytes but also axons and neurons.
